세계의 유리화 시장 - 성장 기회, 성장 촉진요인, 산업 동향 분석과 예측(2024-2032년)

Vitrification Market size is set to record a 10.1% CAGR from 2024 to 2032 driven by escalating infertility rates. Vitrification serves as a pivotal technique for preserving embryos and oocytes for safeguarding reproductive choices for those grappling with fertility issues. In response to the surging demand for fertility treatments, researchers and clinicians are fine-tuning the vitrification process. These enhancements not only bolster the success rates of fertility procedures but also offer robust support to individuals facing infertility challenges. According to a recent WHO report, approximately 1 in 6 individuals globally contend with infertility. This rising trend is propelling the adoption of vitrification methods, aiming to boost success rates in assisted reproductive treatments.

The vitrification industry is segmented into product type, specimen, end-use, and region.

The market share from the kits product type segment will record a decent growth rate between 2024 and 2032. This surge is attributed to the increasing demand for biological sample preservation, achieved by swiftly cooling samples to a glass-like state. Such rapid cooling minimizes ice formation, a crucial factor for the viability of cells and tissues. Vitrification kits also play a pivotal role in applications like stem cell storage and embryo preservation for fine-tuning cooling rates and formulations to enhance preservation success rates.

In terms of specimen, the vitrification market from the embryos segment is anticipated to witness a significant CAGR from 2024-2032. This growth is driven by the imperative to preserve embryos, curbing ice crystal formation and potential cell damage. With ongoing refinements in vitrification protocols, researchers aim to boost embryo preservation and implantation success rates. These advancements promise more effective and dependable embryo preservation methods, aligning with the evolution of fertility treatments and reproductive health.

Asia Pacific vitrification industry size will record a significant CAGR through 2032 due to rising government initiatives and funding. Numerous governments are backing cryopreservation technology research, including vitrification, to bolster fertility treatments and reproductive health. With financial assistance and resources at their disposal, these initiatives aim to elevate technology and its success rates. Such unwavering support underscores the pivotal role of vitrification in advancing reproductive healthcare in APAC.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing demand for fertility treatment
    • 3.2.1.2 Expanding biobanking sector
    • 3.2.1.3 Rising awareness and acceptance of IVF
    • 3.2.1.4 Advancements in cryopreservation technologies
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of vitrification procedure
    • 3.2.2.2 Stringent regulatory requirements
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Pricing analysis
• 3.6 Future market trends
• 3.7 Technology landscape
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Devices
  • 5.2.1 Open system
  • 5.2.2 Closed system
• 5.3 Kits
• 5.4 Reagents and consumables

Chapter 6 Market Estimates and Forecast, By Specimen, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Embryos
• 6.3 Oocytes
• 6.4 Sperms

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 In vitro fertilization clinics
• 7.3 Biobanks

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 The Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Biotech, Inc.
• 9.2 CooperSurgical Fertility Company
• 9.3 FERTIPRO NV
• 9.4 FUJIFILM Irvine Scientific
• 9.5 Genea BIOMEDX
• 9.6 IMV Technologies Group (Cryo Bio System)
• 9.7 Kitazato Corporation.
• 9.8 MFC Global
• 9.9 MINITUB GMBH
• 9.10 NidaCon International AB
• 9.11 Optimas
• 9.12 Shenzhen VitaVitro Biotech
• 9.13 Vitrolife